Edwards C, Monkman S, Cholerton S, Rawlins M D, Idle J R, Ferner R E
Wolfson Unit of Clinical Pharmacology, University of Newcastle upon Tyne.
Br J Clin Pharmacol. 1990 Dec;30(6):889-91. doi: 10.1111/j.1365-2125.1990.tb05456.x.
The pharmacokinetics of nifedipine and its primary oxidised metabolite, M-I were studied in nine healthy volunteers following a single oral dose of 20 mg nifedipine alone or after pretreatment with oral co-trimoxazole. Following pretreatment with co-trimoxazole, no significant effect was detected on maximum plasma concentration, elimination half-life, or area under the plasma concentration-time curve of either nifedipine or M-I, nor on the blood pressure response to nifedipine.
在9名健康志愿者中,研究了单次口服20毫克硝苯地平单独用药或口服复方新诺明预处理后硝苯地平及其主要氧化代谢产物M-I的药代动力学。口服复方新诺明预处理后,未检测到对硝苯地平或M-I的最大血浆浓度、消除半衰期、血浆浓度-时间曲线下面积有显著影响,对硝苯地平的血压反应也无显著影响。